rss
BMJ Case Reports 2012; doi:10.1136/bcr-2012-006361
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Small cell carcinoma of gastro-oesophageal junction with remarkable response to chemo-radiotherapy

  1. Yasutsuna Sasaki1
  1. 1Department of Medical Oncology, International Medical Center, Comprehensive Cancer Center, Saitama Medical University, Hidaka, Japan
  2. 2Department of Surgical Division, Faculty of Medicine, Center for Community Medicine, Oita University, Oita, Japan
  1. Correspondence to Dr Mototsugu Matsunaga, mmandmacgyver{at}yahoo.co.jp

Small cell carcinoma of the gastrointestinal tract is rare, and no effective strategy has yet been established. On the basis of regimens reportedly effective for small cell lung cancer, we performed chemotherapy with cisplatin plus etoposide in combination with radiotherapy to relieve obstruction, in a patient with small cell carcinoma of the gastro-oesophageal junction. Chemotherapy was switched to carboplatin plus etoposide due to renal toxicity. No distant metastases were detected and lesion spread was limited. A complete response, with no evidence of recurrence to date, was achieved. Curative resection was suggested but refused by the patient. He has been closely followed up in our outpatient clinic for more than a year and has shown no evidence of recurrence since the completion of treatment. Although cisplatin plus etoposide is a standard chemotherapy regimen for small cell carcinoma, carboplatin plus etoposide may be effective in cases in which cisplatin is contraindicated due to renal toxicity.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article